Publications
Specialty
Search
Oncology, Journal of Clinical Pathways
06/01/2024
Natasha Leighl, MD, discussed results from the phase 3 PALOMA-3 trial which compared subcutaneous and intravenous amivantamab plus lazertinib in patients with advanced, EGFR-mutated non-small cell lung cancer.
EP Lab Digest
06/01/2024
Featured is the Session 13 Roundtable entitled "The Hype Around Artificial Intelligence (AI): Are We Over-Optimistic About the Future of AI?" from WAFib 2024.
Podiatry Today, Podiatry
06/01/2024
The increasing popularity of indoor cycling may translate to patients who sustain injuries due to improper positioning, shoe gear, and biomechanics. This author reviews basic principles of cycling and shares pertinent advice you can provide to patients on correct positioning and injury prevention.
Podiatry Today
06/01/2024
Although the type of materials used in podiatric surgery can ensure success, such materials can also cause an allergic reaction in patients. These authors break down what podiatric surgeons can do to manage hypersensitivity reactions to metal, sutures, adhesives, and other materials.
Podiatry Today
06/01/2024
Pantalar dislocations are very rare but can be debilitating and difficult to treat. These authors delve into the background, anatomy, epidemiology, clinical presentation, as well as conservative versus surgical treatment options for pantalar dislocations, also presenting a case study of a closed pantalar dislocation.
Podiatry Today
06/01/2024
The focus for this column is 3-fold: functional hallux limitus, symptomatic hallux limitus, and traditional surgical outcomes.
EP Lab Digest
05/31/2024
HCA Florida University Hospital Press Release
DAVIE, Fla. (May 30, 2024) – HCA Florida University Hospital has opened a new electrophysiology (EP) lab, designed to perform advanced procedures for patients suffering from abnormal heartbeats (arrhythmia) and other heart-related conditions.
According to the 2024 Heart Disease and Stroke Statistics: A Report of U.S. and Global Data From the American Heart Association, heart disease has been the leading cause of death in the U.S. for 100 years. Strokes remain the fifth leading cause of death.
Psych Congress Network
05/31/2024
While treatments that improve attention-deficit/hyperactivity disorder (ADHD) in children and adolescents are diverse and growing, medications have the strongest evidence base for improved outcomes.
First Report Managed Care
05/31/2024
A push for a hybrid payment model for primary care is gaining momentum, with advocates urging the CMS to implement changes to increase funding and improve outcomes for patients.
Oncology
05/31/2024
Long-term follow-up results from a phase 2 trial highlight the promising efficacy of azacitidine in combination with ruxolitinib for patients with myelofibrosis.
Oncology
05/31/2024
Cytopenias and/or proliferation, over JAK2 allele burden, correlate with outcomes of patients with primary myelofibrosis and with myelofibrosis from essential thrombocythemia or polycythemia vera, according to data presented at the 2024 Annual ASCO meeting.
Oncology
05/31/2024
According to updated results from the INAVO120 trial, inavolisib plus palbociclib and fulvestrant sustained clinical benefit beyond disease progression among patients with PIK3A-mutated, HR-positive, HER2-negative, locally advanced or metastatic breast cancer.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular, Vascular Disease Management
05/31/2024
Johnson & Johnson announced it has completed its acquisition of Shockwave Medical. Shockwave is now part of Johnson & Johnson and will operate as a business unit within Johnson & Johnson MedTech.
EP Lab Digest
05/31/2024
NEW BRUNSWICK, N.J.—May 31, 2024—Johnson & Johnson today announced it has completed its acquisition of Shockwave Medical. Shockwave is now part of Johnson & Johnson and will operate as a business unit within Johnson & Johnson MedTech.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
05/31/2024
A brief episode of anger triggered by remembering past experiences may negatively impact the blood vessels' ability to relax, which is essential for proper blood flow, according to new research published in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.
Previous research has found that impairment of blood vessels' ability to relax may increase the risk of developing atherosclerosis, which may, in turn, increase the risk of heart disease and stroke.
Psych Congress Network
05/31/2024
Journal of Clinical Pathways
05/31/2024
Barry Russo, MBA, breaks down how collaboration between stakeholders leads to more comprehensive care in value-based care models.
First Report Managed Care
05/31/2024
A new study highlights demographic data on subpopulations of people with multiple sclerosis (MS) in the US based on findings from administrative health claims (AHC) data sets.
EMSWorld
05/31/2024
Venice, Florida's EMS department gets innovative with bikes to help provide emergency care on all terrain—especially where ambulances cannot reach.
Oncology
05/31/2024
Decitabine and cedazuridine plus venetoclax demonstrated efficacy as a fully oral regimen and was found to be safe for older or unfit patients with acute myeloid leukemia, according to a phase 2 study.